Effects of Antenatal Corticosteroid Therapy in Animal Models of Fetal Growth Restriction: a Systematic Review and Meta-analysis

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2025 Mar 14

PMID 40082797

Authors

Mette van de Meent

Dianne G Kleuskens

Jan B Derks

Floris Groenendaal

Wes Onland

Wessel Ganzevoort

A Titia Lely

Carlijn R Hooijmans

Judith Kooiman

Affiliations

Soon will be listed here.

Abstract

Background: Antenatal corticosteroids (CCS) reduce the risks of neonatal morbidity and mortality following spontaneous preterm birth. It is however debated whether effects of antenatal CCS hold for pregnancies complicated by fetal growth restriction (FGR) at risk for preterm birth. This study aimed to summarize effects of antenatal CCS in animal models of FGR by performing a systematic review and meta-analysis.

Methods: The protocol for this systematic review was registered prospectively at PROSPERO (CRD42022318861). A systematic search was performed in PubMed and Embase from inception to April 5th 2023. Animal studies reporting on effects of antenatal CCS compared to placebo or non-treatment in FGR and appropriately grown offspring were included. Primary outcomes were fetal or neonatal mortality, organ developmental parameters (i.e. cardiac, brain, lung), glucose metabolism and fetal weight. Meta-analysis was performed using a random effects model. The quality of the included studies was assessed with the SYRCLE's risk of bias tool.

Results: The literature search yielded 10,386 unique hits. Eight studies were included in the systematic review. In terms of therapeutic effects, lung development and surfactant production were significantly accelerated by antenatal CCS in both FGR and non-FGR. Regarding drug safety, effects of antenatal CCS on fetal weight and brain development were similar for FGR and appropriately grown offspring except for one marker (4-hydroxynonenal) of brain injury, which was more pronounced in FGR offspring. Risk of bias appeared to be unclear for most studies across all domains.

Conclusion: This systematic review illustrates that therapeutic and side effects of antenatal CCS are mainly similar in animal models of FGR as in non-FGR. These findings could therefore support the current recommendation of international guidelines to administer CCS to patients diagnosed with FGR at risk for preterm birth.

References

Lees C, Marlow N, Arabin B, Bilardo C, Brezinka C, Derks J . Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013; 42(4):400-8. DOI: 10.1002/uog.13190. View

Maulik D . Fetal growth restriction: the etiology. Clin Obstet Gynecol. 2006; 49(2):228-35. DOI: 10.1097/00003081-200606000-00006. View

Melamed N, Pittini A, Barrett J, Shah J, Yoon E, Lemyre B . Antenatal Corticosteroids and Outcomes of Small-for-Gestational-Age Neonates. Obstet Gynecol. 2016; 128(5):1001-1008. DOI: 10.1097/AOG.0000000000001674. View

Ting J, Kingdom J, Shah P . Antenatal glucocorticoids, magnesium sulfate, and mode of birth in preterm fetal small for gestational age. Am J Obstet Gynecol. 2018; 218(2S):S818-S828. DOI: 10.1016/j.ajog.2017.12.227. View

Liggins G, Howie R . A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972; 50(4):515-25. View

Zipori Y, Zidan R, Lauterbach R, Hagag A, Ginsberg Y, Solt I . Antenatal betamethasone and the risk of neonatal hypoglycemia: it's all about timing. Arch Gynecol Obstet. 2020; 303(3):695-701. DOI: 10.1007/s00404-020-05785-y. View

Carson R, Monaghan-Nichols A, DeFranco D, Rudine A . Effects of antenatal glucocorticoids on the developing brain. Steroids. 2016; 114:25-32. PMC: 5052110. DOI: 10.1016/j.steroids.2016.05.012. View

Lees C, Stampalija T, Baschat A, da Silva Costa F, Ferrazzi E, Figueras F . ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020; 56(2):298-312. DOI: 10.1002/uog.22134. View

Van der Mierden S, Hooijmans C, Tillema A, Rehn S, Bleich A, Leenaars C . Laboratory animals search filter for different literature databases: PubMed, Embase, Web of Science and PsycINFO. Lab Anim. 2021; 56(3):279-286. PMC: 9194806. DOI: 10.1177/00236772211045485. View

10.

Hooijmans C, Rovers M, De Vries R, Leenaars M, Ritskes-Hoitinga M, Langendam M . SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol. 2014; 14:43. PMC: 4230647. DOI: 10.1186/1471-2288-14-43. View

11.

Menting M, van de Beek C, Mintjens S, Wever K, Korosi A, Ozanne S . The link between maternal obesity and offspring neurobehavior: A systematic review of animal experiments. Neurosci Biobehav Rev. 2019; 98:107-121. DOI: 10.1016/j.neubiorev.2018.12.023. View

12.

Duval S, Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. DOI: 10.1111/j.0006-341x.2000.00455.x. View

13.

Lechner A . Interaction of prenatal starvation and dexamethasone treatment on lung development in newborn guinea pigs. Am Rev Respir Dis. 1987; 135(5):991-6. DOI: 10.1164/arrd.1987.135.5.991. View

14.

Manniello R, Adams A, Farrell P . The influence of antenatal corticosteroids on hypoglycemia in newborn rats with intrauterine growth retardation. Pediatr Res. 1977; 11(7):840-4. DOI: 10.1203/00006450-197707000-00013. View

15.

McKendry A, Palliser H, Yates D, Walker D, Hirst J . The effect of betamethasone treatment on neuroactive steroid synthesis in a foetal Guinea pig model of growth restriction. J Neuroendocrinol. 2010; 22(3):166-74. DOI: 10.1111/j.1365-2826.2009.01949.x. View

16.

Miller S, Sutherland A, Supramaniam V, Walker D, Jenkin G, Wallace E . Antenatal glucocorticoids reduce growth in appropriately grown and growth-restricted ovine fetuses in a sex-specific manner. Reprod Fertil Dev. 2012; 24(5):753-8. DOI: 10.1071/RD11143. View

17.

Miller S, Chai M, Loose J, Castillo-Melendez M, Walker D, Jenkin G . The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology. 2006; 148(3):1288-95. DOI: 10.1210/en.2006-1058. View

18.

Tare M, Miller S, Wallace E, Sutherland A, Yawno T, Coleman H . Glucocorticoid treatment does not alter early cardiac adaptations to growth restriction in preterm sheep fetuses. BJOG. 2012; 119(8):906-14. DOI: 10.1111/j.1471-0528.2012.03309.x. View

19.

Sutherland A, Crossley K, Allison B, Jenkin G, Wallace E, Miller S . The effects of intrauterine growth restriction and antenatal glucocorticoids on ovine fetal lung development. Pediatr Res. 2012; 71(6):689-96. DOI: 10.1038/pr.2012.19. View

20.

Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, STEIN H . Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984; 133(4):1710-5. View